Schwab Officer Reports Multiple Sales Under 10b5-1 Plan
Rhea-AI Filing Summary
Paul V. Woolway, MD, Chief Banking Officer of Schwab Charles Corp (SCHW), reported multiple sales of company common stock on 10/01/2025. The Form 4 shows two Rule 10b5-1 plan sales of 1,913 and 1,292 shares (both marked S(1)) and another reported disposal of 25,153 shares. The reporting person states the sales were made under a Rule 10b5-1 trading plan adopted on November 15, 2024. Execution occurred in multiple trades at prices ranging from $92.49 to $94.25, with weighted average prices reported as $93.0449 and $93.7434. The Form 4 was signed by an attorney-in-fact on 10/02/2025.
Positive
- Sales were executed under a Rule 10b5-1 plan adopted on November 15, 2024
- Form 4 discloses weighted average prices and price ranges ($92.49–$94.25) and offers to provide full trade details upon request
- Form 4 was signed by an attorney-in-fact on 10/02/2025, indicating timely filing following the trades
Negative
- Reporting person disposed of 25,153 shares (plus separate sales of 1,913 and 1,292 shares) which reduces insider holdings
- Some ownership lines and totals in the table are ambiguous, requiring supplemental detail for precise post-transaction holdings
Insights
Insider sold shares under a pre-established 10b5-1 plan on 10/01/2025.
The filing documents sales of 1,913 and 1,292 shares executed in multiple trades and a listed disposal of 25,153 shares. The reporting person disclosed the plan adoption date as November 15, 2024, and provided weighted average sale prices of $93.0449 and $93.7434.
This matters because the filing shows the trades were pre-authorized under a Rule 10b5-1 plan, and the execution prices span $92.49–$94.25, details that are relevant to transaction timing and proceeds but do not, by themselves, disclose intent.
Filing confirms required disclosure and use of attorney-in-fact signature on 10/02/2025.
The Form 4 identifies the reporting person as an officer (MD, Chief Banking Officer) and includes an attorney-in-fact signature (P. Blake Allen), indicating the filing was executed promptly after the trades. The explanatory notes include price ranges and a willingness to provide full trade details on request.
That transparency fulfills Section 16 reporting mechanics; the filing contains explicit trade counts and price ranges but does not disclose proceeds or purpose of sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 1,913 | $93.0449 | $178K |
| Sale | Common Stock | 1,292 | $93.7434 | $121K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024. This transaction was executed in multiple trades at prices ranging from $92.49 to $93.44. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. This transaction was executed in multiple trades at prices ranging from $93.54 to $94.25. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
